Lifelong Vision Foundation administers clinical studies and funds independent research studies at Pepose Vision Institute in partnership with the Pepose Vision physicians. These studies play a leading role in the advancement of vision care. If you think you or a family member might be a candidate for any of the studies listed below, please call Lee Stolze, our Clinical Research Manager, at 636-534-5126.


Studies include:

  • AMD – Age-Related Macular Degeneration
  • Catatact
  • Conjunctivitis (pink eye)
  • Diabetic Retinopathy
  • Dry Eye
  • Glaucoma
  • Keratoconus
  • Presbyopia
  • Uveitis
  • And more


Benefits of participating in a study:

Clinical studies offer a great opportunity for our patients to receive the most advanced vision treatment possible, generally years before the general public, often at a discounted price and/or with other benefits. Some studies provide patient compensation.


Current Clinical Studies: 

AMD (Age-Related Macular Degeneration) Dry or Wet

• TOGA (University of Virginia): Low-dose oral (pill) doxycycline for slowing the progression of advance Geographic Atrophy due to Dry AMD

• LADDER (Genentech): Long-term drug (device) delivery of Lucentis for treatment of wet AMD

• IMT-PAS Telescopic Lens (Vision Care Technologies): A registry study of the implantable (device) miniature telescope for advanced AMD


• EyeGate (EyeGate Pharma): Comparing two delivery systems of a ophthalmic solution or suspension in patients with Non-Infectious Uveitis

Dry Eyes

• Kala (Kala Pharma): Eye Drop study for Dry Eyes

• Xiidra; lifitegrast (LVF): Further research of the effect of FDA approved Lifitegrast on dry eye disease signs and symptoms


• Bimatoprost SR: 192024-091 (Allergan): Implant that may lower the IOP (intraocular pressure) in patients with Glaucoma or Ocular Hypertension


•SHP640-301 and SHP640-303 (Shire): Adenoviral or Bacterial Conjunctivitis; Eye Drop comparison study


For more information, please call Lee Stolze, our Clinical Research Manager, at 636-534-5126 or email her at  Please include your first and last name and phone number if you choose to send us an email.


Our goals are achieved through the generous support of patients and their family members, corporate citizens and foundations who share the vision of lifelong excellence in eye care. Your support is most appreciated.